Category archives for: Business

EVP, Research & Investments of Royalty Pharma Plc (NASDAQ:RPRX), Reddoch James F., sells 100,000 shares worth $4,692,158

According to Royalty Pharma Plc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 07:02 PM, company EVP, Research & Investments, Reddoch James F. disclosed selling 100,000 shares at a cost of $46.92. At the time of this transaction (Mar 02), this trade was worth $4,692,158 […]

Director of Shotspotter, Inc (NASDAQ:SSTI), Levensohn Pascal, sells 4,991 shares worth $196,468

According to Shotspotter, Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 05:55 PM, company Director, Levensohn Pascal disclosed selling 4,991 shares at a cost of $39.36. At the time of this transaction (Mar 02), this trade was worth $196,468 in total. As of Mar […]

EVP & CFO of Royalty Pharma Plc (NASDAQ:RPRX), Coyne Terrance P., sells 100,000 shares worth $4,694,090

According to Royalty Pharma Plc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 07:00 PM, company EVP & CFO, Coyne Terrance P. disclosed selling 100,000 shares at a cost of $46.94. At the time of this transaction (Mar 02), this trade was worth $4,694,090 in […]

Chief Scientific Officer of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), Roberts Christopher D., sells 2,500 shares worth $65,262

According to Black Diamond Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 05:52 PM, company Chief Scientific Officer, Roberts Christopher D. disclosed selling 2,500 shares at a cost of $26.10. At the time of this transaction (Mar 03), this trade was worth $65,262 […]

Chief Accounting Officer of Trimas Corp (NASDAQ:TRS), Swart Paul, sells 3,399 shares worth $107,442

According to Trimas Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 06:58 PM, company Chief Accounting Officer, Swart Paul disclosed selling 3,399 shares at a cost of $31.61. At the time of this transaction (Mar 04), this trade was worth $107,442 in total. As […]

Chief Financial Officer of Novocure Ltd (NASDAQ:NVCR), Cordova Ashley, sells 428 shares worth $65,079

According to Novocure Ltd’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 05:52 PM, company Chief Financial Officer, Cordova Ashley disclosed selling 428 shares at a cost of $152.05. At the time of this transaction (Mar 02), this trade was worth $65,079 in total. As […]

Senior Vice President of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Walkey Carl, sells 1,800 shares worth $21,360

According to Neoleukin Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 06:52 PM, company Senior Vice President, Walkey Carl disclosed selling 1,800 shares at a cost of $11.87. At the time of this transaction (Mar 03), this trade was worth $21,360 in total. […]

Chief Operating Officer of Novocure Ltd (NASDAQ:NVCR), Groenhuysen Wilhelmus Cm, sells 2,392 shares worth $363,711

According to Novocure Ltd’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 05:50 PM, company Chief Operating Officer, Groenhuysen Wilhelmus Cm disclosed selling 2,392 shares at a cost of $152.05. At the time of this transaction (Mar 02), this trade was worth $363,711 in total. […]

10% Owner of Federal Agricultural Mortgage Corp (NYSE:AGM), Zions Bancorporation, National, sells 10,000 shares worth $884,271

According to Federal Agricultural Mortgage Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 06:51 PM, company 10% Owner, Zions Bancorporation, National disclosed selling 10,000 shares at a cost of $88.43. At the time of this transaction (Mar 04), this trade was worth $884,271 in […]

Chief Commercial Officer of Novocure Ltd (NASDAQ:NVCR), Shah Pritesh, sells 912 shares worth $138,672

According to Novocure Ltd’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Mar 04 05:46 PM, company Chief Commercial Officer, Shah Pritesh disclosed selling 912 shares at a cost of $152.05. At the time of this transaction (Mar 02), this trade was worth $138,672 in total. As […]

Featured Press Releases

Photo Gallery

Log in